abstract |
The present invention relates to novel drugs that are effective in treating cancers containing double helix RNA, such as I n C n . Specifically, the present invention relates to a carrier prepared with 2-0- (2-diethylaminoethyl) carbamoyl-1,3-0-dioleoylglycerol, and a phospholipid as a main component, and I n · C n or mismatch. A nuclease activator in cancer cells containing a complex with I n · C n . |